Cart
sales@molnova.com
Nesuparib
CAS No. 2055357-64-5
Nesuparib( —— )
Catalog No. M35605 CAS No. 2055357-64-5
Nesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 137 | Get Quote |
|
| 5MG | 211 | Get Quote |
|
| 10MG | 337 | Get Quote |
|
| 25MG | 586 | Get Quote |
|
| 50MG | 799 | Get Quote |
|
| 100MG | 1062 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNesuparib
-
NoteResearch use only, not for human use.
-
Brief DescriptionNesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.
-
DescriptionNesuparib is a potent inhibitor of PARP. Nesuparib is useful for the research of neuropathic pain, neurodegenerative disease, and cardiovascular disease (extracted from patent WO2016200101A2).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin | PARP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2055357-64-5
-
Formula Weight400.48
-
Molecular FormulaC23H24N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 62.5 mg/mL (156.06 mM )
-
SMILESO=c1[nH]c2cc(CN3CCN(CC3)c3ccc(cn3)C#N)ccc2c2NCCCc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same. Patent WO2016200101A2.
molnova catalog
related products
-
TNIK-IN-5
TNIK-IN-5 is an inhibitor of TNIK and can be used in studies about the treatment of anti-tumor and anti-inflammatory diseases.
-
Neurodazine
Neurodazine is a neural inducer that promotes the differentiation of pluripotent cells into neuronal cells.Neurodazine promotes differentiation by activating Wnt and Shh signaling.
-
TNIK-IN-7
TNIK-IN-7 is a potent and selective Traf2 and Nck interacting kinase (TNIK) inhibitor (IC50: 11 nM) with antitumor activity for studying signaling and proliferation in colorectal cancer cells.
